Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Intel Expands Its Pharmaceutical R&D

|Includes:Intel Corporation (INTC)

Intel Corporation (NASDAQ: INTC) investors understand that R&D spending means more growth returns than they pay for. Intel's Pharmaceutical R&D is capitalizing on research. Intel announced a deal last month to make "field-programmable gate arrays" for Altera (NASDAQ:ALTR). Intel and Altera will be collaborating to transition into developing high-end high performance next-generation of field-programmable gate array (FPGA) chips. Intel expects to have Altera gain a significant advantage over its rivals in the FPGA market. The next-generation products target ultra high-performance systems for military, wireline communications, cloud networking, and compute and storage applications. Intel claims by offering access to its patented tri-gate transistor technology benefits can significantly boost performance or reduce power consumption...

Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.

Stocks: INTC